A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ataxia

Condition:   Friedreich Ataxia Interventions:   Biological: CTI-1601;   Other: Placebo Sponsor:   Larimar Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials